Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CG Oncology, Inc. | 200,763 | reported | 12 Mar 2026 | tx 8+1,092,943−172,201 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | TAX_WITHHOLDING | CG Oncology, Inc. | 1,847 | 60.15 USD | |
| 12 Mar 2026 | EXERCISE | CG Oncology, Inc. | 64,612 | 1.72 USD | |
| 12 Mar 2026 | EXERCISE | CG Oncology, Inc. | 64,612 | 0.00 USD | deriv |
| 04 Mar 2026 | EXERCISE | CG Oncology, Inc. | 102,871 | 1.72 USD | |
| 04 Mar 2026 | TAX_WITHHOLDING | CG Oncology, Inc. | 2,871 | 61.61 USD | |
| 04 Mar 2026 | EXERCISE | CG Oncology, Inc. | 102,871 | 0.00 USD | deriv |
| 15 Apr 2025 | GRANT_AWARD | CG Oncology, Inc. | 527,660 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | CG Oncology, Inc. | 397,800 | 0.00 USD | deriv |